Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Rachel Van Swelm"'
Autor:
Melissa A. Claus, Lisa Smart, Anthea L. Raisis, Claire R. Sharp, Sam Abraham, Joel P. A. Gummer, Martin K. Mead, Damian L. Bradley, Rachel Van Swelm, Erwin T. G. Wiegerinck, Edward Litton
Publikováno v:
Veterinary Sciences, Vol 10, Iss 2, p 121 (2023)
Red blood cell (RBC) transfusion is associated with recipient inflammation and infection, which may be triggered by excessive circulating iron. Iron chelation following transfusion may reduce these risks. The aim of this study was to evaluate the eff
Externí odkaz:
https://doaj.org/article/bedc99766b3045f5a5fa34043d8d84dd
Autor:
Laura Diepeveen, Rian Roelofs, Nicolai Grebenchtchikov, Rachel van Swelm, Leon Kautz, Dorine Swinkels
Publikováno v:
PLoS ONE, Vol 16, Iss 7, p e0254851 (2021)
Erythroferrone (ERFE), the erythroid regulator of iron metabolism, inhibits hepcidin to increase iron availability for erythropoiesis. ERFE plays a pathological role during ineffective erythropoiesis as occurs in X-linked sideroblastic anemia (XLSA)
Externí odkaz:
https://doaj.org/article/173e5fa918e9448cb8c2232858c56c27
Autor:
Lutz Renders, Klemens Budde, Christian Rosenberger, Rachel van Swelm, Dorine Swinkels, Frank Dellanna, Werner Feuerer, Ming Wen, Christiane Erley, Birgit Bader, Claudia Sommerer, Matthias Schaier, Karoline Meurer, Louis Matis
Publikováno v:
PLoS ONE, Vol 14, Iss 3, p e0212023 (2019)
In chronic kidney disease both renal insufficiency and chronic inflammation trigger elevated hepcidin levels, which impairs iron uptake, availability. and erythropoiesis. Here we report the two first-in-human phase 1 trials of PRS-080#22, a novel, ra
Externí odkaz:
https://doaj.org/article/936377bd297b46aa88a277ec34cc06df